Hasan Al Banna

Hasan Al Banna

Auto-generated profile, based on publicly available information

Hasan Al Banna

Institute of Social Welfare and Research, University of Dhaka, Dhaka 1000, Bangladesh

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Risk Management and Healthcare Policy
Verified
Journal Article
Open access
PDF file
NSNandeeta Samad
Nandeeta Samad
TSTemitayo Eniola Sodunke
Temitayo Eniola Sodunke
HBHasan Al Banna
Hasan Al Banna
ASAshmita Sapkota
Ashmita Sapkota
AFAneeka Nawar Fatema
Aneeka Nawar Fatema
MHMainul Haque
Mainul Haque
The world is striving against the severe crisis of the COVID-19 pandemic. Healthcare professionals are struggling to treat their patients based on nonspecific therapies. Amidst this uncertainty, convalescent plasma therapy (CPT) has appeared to be an interim adjuvant therapy for severely ill patients of COVID-19 until long-term clinical trial treatment options are available. Considering the transfusion-related hazards, especially lung injuries and microbial transmission, where sensitivity is not ensured, rigorous trials should be conducted to determine this therapy’s efficacy. Moreover, the ratio of recovered cases to plasma donors is not satisfying, which questioning this therapy’s availability and accessibility. Although some countries are making the treatment free, the attributable cost mandates a justification for its suitability and sustainability. Our article aimed to review the published facts and findings of CPT’s effectiveness in lowering the mortality rate of COVID-19. This pandemic showed that healthcare systems worldwide need core reform. A unified global collaboration must align and coordinate to face the current pandemic and enhance world readiness for future outbreaks based on health equity and equality.